Regulation of dimethyl-fumarate toxicity by proteasome inhibitors

The present studies examined the biology of the multiple sclerosis drug dimethyl-fumarate (DMF) or its in vivo breakdown product and active metabolite mono-methyl-fumarate (MMF), alone or in combination with proteasome inhibitors, in primary human glioblastoma (GBM) cells. MMF enhanced velcade and c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Biol Ther
Autors principals: Booth, Laurence, Cruickshanks, Nichola, Tavallai, Seyedmehrad, Roberts, Jane L, Peery, Matthew, Poklepovic, Andrew, Dent, Paul
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2014
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623310/
https://ncbi.nlm.nih.gov/pubmed/25482938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15384047.2014.967992
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars